VTRS (NASDAQ) - Viatris Inc

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92556V1061
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Web URL: https://www.viatris.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for VTRS (NASDAQ) - Viatris Inc


Market Cap in USD 12,973m
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 2020-11-16


Fundamental 0.96
Dividend 3.26
Performance 5y -5.25
Rel. Performance vs Sector 0.18
Analysts 3.36
Fair Price Total Ret. 7.42
Fair Price DCF todo


Growth TTM 13.81%
CAGR 5y -22.59%
CAGR / Mean Drawdown 5y -0.40
Sharpe Ratio TTM 0.28
Alpha vs SP500 TTM -2.11
Beta vs SP500 5y weekly 0.82
CAPM 7.13%
Average Daily Range 2m 2.26%
Reversal Oscillator 20.26
Volatility GJR Garch 1y 38.33%
Price / SMA 50 -7.16%
Price / SMA 200 -4.8%
Current Volume 5417.6k
Average Volume 20d 8852.8k


Yield TTM 4.94%
Yield on Cost 5y 1.43%
Dividends CAGR 5y 4.45%
Consistency of Dividends all time 58.2%